CDW vs REGN · P/E 22, rev $21.00B vs P/E 14, rev $14.34B
CDW Corp (CDW) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
CDW Corp (CDW) is a information technology services company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CDW revenue for 2024-12-31 was $21.00B. Net income was $1.08B. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CDW currently screens at market cap $23.36B and trailing P/E 22.0.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CDW currently screens at market cap $23.36B and trailing P/E 22.0. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CDW and REGN stock pages for the full models.
Not investment advice.